PitchBook-2025年一季度Healthtech公共报表和估值指南（英）-2025

2025-04资本市场10免费

📄 文件全名: 《PitchBook-2025年一季度Healthtech公共报表和估值指南（英）-2025-10页.pdf》
🎯 适合读者: 投资人行业研究员
📊 核心数据: 58% and 26%, respectively. Looking ahead, the digital aspect of most healthtech companies should limit negative effects from
TA Associates Management. The Accolade deal valued the company at $621 million, a more than 100% premium from its pre-
🏷️ 核心议题: #IPO

📦 本报告属于月份合集

购买后将获得「2025 年 4 月报告合集」 · 共 5240 份报告打包下载链接

点击获取云盘下载链接

报告摘要

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research

❓ 常见问题

《PitchBook-2025年一季度Healthtech公共报表和估值指南（英）-2025》主要包含哪些内容?

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research核心数据:58% and 26%, respectively. Looking ahead, the digital aspect of most healthtech companies should limit negative effects from;TA Associates Management. The Accolade deal valued the company at $621 million, a more than 100% premium from its pre-。

这份报告覆盖哪一年、篇幅多大?

覆盖 2025 年,全文约 10。

这份报告是免费的吗?如何获取?

本报告免费查阅,登录资料宝后即可在线获取完整内容。

这份报告适合哪些读者?

适合投资人、行业研究员等读者参考。

报告涉及哪些关键议题?

重点分析了IPO等议题。